Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment
Clinical trial NCT04632927 · COMPLETED
Trial details
- NCT number
- NCT04632927
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2024-10-22
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.